In addition, because multiple receptor tyrosine kinases are overexpressed in thyroid cancer, TKIs represent promising new strategies for the treatment of advanced thyroid cancers; in particular, TKIs have been shown to have potential in differentiated thyroid carcinoma [12, 13]. The gene discussed is NTRK1; the disease is differentiated thyroid carcinoma.